The effect of tirapazamme (SR4233) alone or combined with chemotherapeutic agents on xenografted human tumours
1996

Effects of Tirapazamine on Human Tumors

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): E Lartigau, M Guichard

Primary Institution: Institut Gustave Roussy

Hypothesis

The study aims to define the toxicity and activity of tirapazamine alone and in combination with chemotherapy agents on xenografted human tumors.

Conclusion

Tirapazamine was shown to be cytotoxic against clonogenic human tumor cells, and its efficacy may depend on its combination with active chemotherapy drugs.

Supporting Evidence

  • The combination of tirapazamine and bleomycin significantly increased the delay of regrowth compared with bleomycin alone.
  • The combination of tirapazamine with VP16 significantly increased tumor doubling time compared with controls.
  • Tirapazamine was more cytotoxic than VP16 alone.

Takeaway

Tirapazamine can help kill cancer cells when used with other drugs, but it can also make the treatment more dangerous for mice.

Methodology

The study used animal lethality, growth delay assays, and excision assays on nude mice with xenografted tumors.

Limitations

The study was conducted on mice, which may not fully represent human responses.

Participant Demographics

Nude mice bearing xenografted human tumors (rectal carcinoma and melanoma).

Statistical Information

P-Value

p=0.0001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication